Oral selinexor/pomalidomide/dexamethasone shows activity in heavily pre-treated multiple myeloma Presented ByDr Christine Chen, Princess Margaret Cancer Centre, University of Toronto, Canada TrialMM-003, STOMP ConferenceASH 2019 TypePeer-reviewed article 5 March 2020 22:59